[General immunologic complications of insulin therapy].
D000305:Adrenal Cortex Hormones / Q000627:therapeutic use; D000906:Antibodies; D003888:Desensitization, Immunologic; D003920:Diabetes Mellitus / Q000188:drug therapy; D004342:Drug Hypersensitivity / Q000188:drug therapy / Q000276:immunology* / Q000628:therapy; D000939:Epitopes; D006634:Histamine H1 Antagonists / Q000627:therapeutic use; D006801:Humans; D006968:Hypersensitivity, Delayed / Q000276:immunology; D006969:Hypersensitivity, Immediate / Q000276:immunology; D007004:Hypoglycemic Agents / Q000627:therapeutic use; D007111:Immunity, Cellular; D007166:Immunosuppressive Agents / Q000494:pharmacology; D007328:Insulin / Q000009:adverse effects* / Q000627:therapeutic use; D007330:Insulin Antibodies / Q000302:isolation & purification; D007333:Insulin Resistance / Q000187:drug effects; D013045:Species Specificity
D000305:Adrenal Cortex Hormones; D000906:Antibodies; D000939:Epitopes; D006634:Histamine H1 Antagonists; D007004:Hypoglycemic Agents; D007166:Immunosuppressive Agents; D007328:Insulin; D007330:Insulin Antibodies
Complicanze generali immunologiche della terapia insulinica.